A.R.T. Advisors’s Cymabay Therapeutics CBAY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-195,480
| Closed | -$383K | – | 1089 |
|
|
2019
Q4 | $383K | Buy |
195,480
+153,541
| +366% | +$301K | 0.02% | 945 |
|
|
2019
Q3 | $215K | Sell |
41,939
-42,500
| -50% | -$218K | 0.01% | 1167 |
|
|
2019
Q2 | $605K | Buy |
84,439
+28,923
| +52% | +$207K | 0.03% | 673 |
|
|
2019
Q1 | $737K | Buy |
55,516
+43,300
| +354% | +$575K | 0.04% | 590 |
|
|
2018
Q4 | $96K | Sell |
12,216
-43,599
| -78% | -$343K | 0.01% | 1170 |
|
|
2018
Q3 | $618K | Buy |
+55,815
| New | +$618K | 0.03% | 762 |
|
|
2018
Q2 | – | Sell |
-57,631
| Closed | -$748K | – | 1828 |
|
|
2018
Q1 | $748K | Buy |
57,631
+42,400
| +278% | +$550K | 0.03% | 777 |
|
|
2017
Q4 | $140K | Buy |
+15,231
| New | +$140K | 0.01% | 1220 |
|
|
2015
Q3 | – | Sell |
-36,069
| Closed | -$97K | – | 1660 |
|
|
2015
Q2 | $97K | Buy |
36,069
+20,940
| +138% | +$56.3K | ﹤0.01% | 1370 |
|
|
2015
Q1 | $104K | Buy |
+15,129
| New | +$104K | ﹤0.01% | 1315 |
|